Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:21634377rdf:typepubmed:Citationlld:pubmed
pubmed-article:21634377lifeskim:mentionsumls-concept:C0020792lld:lifeskim
pubmed-article:21634377lifeskim:mentionsumls-concept:C0030193lld:lifeskim
pubmed-article:21634377lifeskim:mentionsumls-concept:C0026336lld:lifeskim
pubmed-article:21634377lifeskim:mentionsumls-concept:C0442027lld:lifeskim
pubmed-article:21634377lifeskim:mentionsumls-concept:C0949307lld:lifeskim
pubmed-article:21634377lifeskim:mentionsumls-concept:C1419867lld:lifeskim
pubmed-article:21634377lifeskim:mentionsumls-concept:C0205322lld:lifeskim
pubmed-article:21634377lifeskim:mentionsumls-concept:C1999216lld:lifeskim
pubmed-article:21634377pubmed:issue13lld:pubmed
pubmed-article:21634377pubmed:dateCreated2011-7-7lld:pubmed
pubmed-article:21634377pubmed:abstractTextClinical human genetic studies have recently identified the tetrodotoxin (TTX) sensitive neuronal voltage gated sodium channel Nav1.7 (SCN9A) as a critical mediator of pain sensitization. Herein, we report structure-activity relationships for a novel series of 2,4-diaminotriazines that inhibit hNav1.7. Optimization efforts culminated in compound 52, which demonstrated pharmacokinetic properties appropriate for in vivo testing in rats. The binding site of compound 52 on Nav1.7 was determined to be distinct from that of local anesthetics. Compound 52 inhibited tetrodotoxin-sensitive sodium channels recorded from rat sensory neurons and exhibited modest selectivity against the hERG potassium channel and against cloned and native tetrodotoxin-resistant sodium channels. Upon oral administration to rats, compound 52 produced dose- and exposure-dependent efficacy in the formalin model of pain.lld:pubmed
pubmed-article:21634377pubmed:languageenglld:pubmed
pubmed-article:21634377pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21634377pubmed:citationSubsetIMlld:pubmed
pubmed-article:21634377pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21634377pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21634377pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21634377pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21634377pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21634377pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21634377pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21634377pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21634377pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21634377pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21634377pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21634377pubmed:statusMEDLINElld:pubmed
pubmed-article:21634377pubmed:monthJullld:pubmed
pubmed-article:21634377pubmed:issn1520-4804lld:pubmed
pubmed-article:21634377pubmed:authorpubmed-author:LiuDongDlld:pubmed
pubmed-article:21634377pubmed:authorpubmed-author:AntónM PMPlld:pubmed
pubmed-article:21634377pubmed:authorpubmed-author:McDonoughStef...lld:pubmed
pubmed-article:21634377pubmed:authorpubmed-author:HuangLiyueLlld:pubmed
pubmed-article:21634377pubmed:authorpubmed-author:JohnsonDaniel...lld:pubmed
pubmed-article:21634377pubmed:authorpubmed-author:NguyenHanh...lld:pubmed
pubmed-article:21634377pubmed:authorpubmed-author:DiMauroErin...lld:pubmed
pubmed-article:21634377pubmed:authorpubmed-author:McDermottJeff...lld:pubmed
pubmed-article:21634377pubmed:authorpubmed-author:HierlMarkusMlld:pubmed
pubmed-article:21634377pubmed:authorpubmed-author:MatsonDavidDlld:pubmed
pubmed-article:21634377pubmed:authorpubmed-author:BregmanHoward...lld:pubmed
pubmed-article:21634377pubmed:authorpubmed-author:ImmkeDavidDlld:pubmed
pubmed-article:21634377pubmed:authorpubmed-author:LiguttiJoseph...lld:pubmed
pubmed-article:21634377pubmed:authorpubmed-author:MalmbergAnnik...lld:pubmed
pubmed-article:21634377pubmed:authorpubmed-author:WaldonDanielDlld:pubmed
pubmed-article:21634377pubmed:authorpubmed-author:LiXingwenXlld:pubmed
pubmed-article:21634377pubmed:authorpubmed-author:BuchananJohn...lld:pubmed
pubmed-article:21634377pubmed:authorpubmed-author:PatelVinod...lld:pubmed
pubmed-article:21634377pubmed:authorpubmed-author:BerryLorenLlld:pubmed
pubmed-article:21634377pubmed:authorpubmed-author:FericElmaElld:pubmed
pubmed-article:21634377pubmed:authorpubmed-author:ChenAprilAlld:pubmed
pubmed-article:21634377pubmed:authorpubmed-author:JanoskyBrettBlld:pubmed
pubmed-article:21634377pubmed:authorpubmed-author:ZhengXiao...lld:pubmed
pubmed-article:21634377pubmed:authorpubmed-author:DuBingfanBlld:pubmed
pubmed-article:21634377pubmed:authorpubmed-author:MiuPeterPlld:pubmed
pubmed-article:21634377pubmed:authorpubmed-author:WilenkinBenBlld:pubmed
pubmed-article:21634377pubmed:issnTypeElectroniclld:pubmed
pubmed-article:21634377pubmed:day14lld:pubmed
pubmed-article:21634377pubmed:volume54lld:pubmed
pubmed-article:21634377pubmed:ownerNLMlld:pubmed
pubmed-article:21634377pubmed:authorsCompleteYlld:pubmed
pubmed-article:21634377pubmed:pagination4427-45lld:pubmed
pubmed-article:21634377pubmed:meshHeadingpubmed-meshheading:21634377...lld:pubmed
pubmed-article:21634377pubmed:meshHeadingpubmed-meshheading:21634377...lld:pubmed
pubmed-article:21634377pubmed:meshHeadingpubmed-meshheading:21634377...lld:pubmed
pubmed-article:21634377pubmed:meshHeadingpubmed-meshheading:21634377...lld:pubmed
pubmed-article:21634377pubmed:meshHeadingpubmed-meshheading:21634377...lld:pubmed
pubmed-article:21634377pubmed:meshHeadingpubmed-meshheading:21634377...lld:pubmed
pubmed-article:21634377pubmed:meshHeadingpubmed-meshheading:21634377...lld:pubmed
pubmed-article:21634377pubmed:meshHeadingpubmed-meshheading:21634377...lld:pubmed
pubmed-article:21634377pubmed:meshHeadingpubmed-meshheading:21634377...lld:pubmed
pubmed-article:21634377pubmed:meshHeadingpubmed-meshheading:21634377...lld:pubmed
pubmed-article:21634377pubmed:meshHeadingpubmed-meshheading:21634377...lld:pubmed
pubmed-article:21634377pubmed:meshHeadingpubmed-meshheading:21634377...lld:pubmed
pubmed-article:21634377pubmed:meshHeadingpubmed-meshheading:21634377...lld:pubmed
pubmed-article:21634377pubmed:meshHeadingpubmed-meshheading:21634377...lld:pubmed
pubmed-article:21634377pubmed:meshHeadingpubmed-meshheading:21634377...lld:pubmed
pubmed-article:21634377pubmed:meshHeadingpubmed-meshheading:21634377...lld:pubmed
pubmed-article:21634377pubmed:meshHeadingpubmed-meshheading:21634377...lld:pubmed
pubmed-article:21634377pubmed:meshHeadingpubmed-meshheading:21634377...lld:pubmed
pubmed-article:21634377pubmed:meshHeadingpubmed-meshheading:21634377...lld:pubmed
pubmed-article:21634377pubmed:meshHeadingpubmed-meshheading:21634377...lld:pubmed
pubmed-article:21634377pubmed:meshHeadingpubmed-meshheading:21634377...lld:pubmed
pubmed-article:21634377pubmed:meshHeadingpubmed-meshheading:21634377...lld:pubmed
pubmed-article:21634377pubmed:meshHeadingpubmed-meshheading:21634377...lld:pubmed
pubmed-article:21634377pubmed:year2011lld:pubmed
pubmed-article:21634377pubmed:articleTitleIdentification of a potent, state-dependent inhibitor of Nav1.7 with oral efficacy in the formalin model of persistent pain.lld:pubmed
pubmed-article:21634377pubmed:affiliationDepartment of Chemistry Research and Discovery, Amgen Inc., Cambridge, Massachusetts 02142, United States. hbregman@amgen.comlld:pubmed
pubmed-article:21634377pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:21634377pubmed:publicationTypeIn Vitrolld:pubmed
http://linkedlifedata.com/r...http://linkedlifedata.com/r...pubmed-article:21634377lld:chembl